February 14, 2024
The US FDA on February 12 handed out the green light for Takeda Pharmaceutical’s Eohilia (budesonide oral suspension) after a resubmission, making it the first and only oral drug approved for the treatment of eosinophilic esophagitis (EoE) in the country...read more